ARCHIVES

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Encourages New Regional Cooperative Groups

November 19, 1976

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

DCT Board Oks Limited Support For Development Of Neutron Therapy

March 31, 1978

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014